Pharmaceutical Pricing Quotes

Professionalism in medicine has given us medial miracles for the affluent but hospitals that will charge $35 for aspirin.

We've had a long wrangle with the pharmaceutical industry about parallel imports, and what we were saying is we want to make medicines and drugs as affordable as a possible to what is largely a poor population.

If you have a drug that is $100 for one course of therapy, and you know that you can charge $100,000, what should shareholders think when you say, 'I'd rather not take the heat'?

The pharma pricing system was not built on the idea of consumer engagement. It was built... on market efficiencies. It was not built on the premise of consumerism.

Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even more complex and expensive. Simple economics dictates that companies and venture funds will invest more in products that can generate a sufficient return.

As a doctor, my thing is, we need to have access to medications; we need to have reasonable prices for medications.

We pay so much more for the same pill, prescription drugs than other countries. You go to Canada - people go to Canada to buy prescriptions. So we're subsidizing the world in terms of prescription drugs. It's ridiculous. And it's going to stop. The problem I have is these companies give so much - I mean the contributions are massive, just massive, the amount. But we do have - there are a lot of good people that are seeing what's going on. And I think we'll be successful in that. Next week, I'm going to declaring an emergency, national emergency on drugs.

It's not enough just to be in a panic. We don't have the luxury to be depressed about Trump. We have to look at issues like health care and the price of pharmaceuticals, the $15 minimum wage and things that actually make a huge difference in a lot of people's lives. That's feminist.

We need to work on drug costs, and there's things we can work on on drug costs, especially Medicare Part D, to bring drug costs down.

From the point of view of the pharmaceutical industry, the AIDS problem has already been solved. After all, we already have a drug which can be sold at the incredible price of $8,000 an annual dose, and which has the added virtue of not diminishing the market by actually curing anyone.

First of all, pharmaceutical costs are the single fastest-growing part of our health care budget.

To drive down high drug costs, we need to shine a light on the negotiations between drug manufacturers, middleman negotiators and pharmacies.

The first and pivotal negotiations over global access to AIDS drugs began in Geneva in 1991. They lasted two years, but confidential minutes suggest they were doomed the first day.

The way we have looked at pricing at Merck is we've always said we want to be responsible, which means we want to optimize profitability and patient access.

Prescription drug prices are skyrocketing and one-third of all seniors depend on Social Security for at least 90% of their income.

The cost of prescription drugs in this country is far, far higher than in any other country. You may recall that Donald Trump as a candidate for president talked about how he was going to take on the pharmaceutical industry and it was going to lower prescription drug costs.

In the domain of pharmaceuticals, we need a metric for health impact, and with this metric we can then assess the value of the introduction of a new product and pay its innovator accordingly, say on the basis of the product's measured health impact during its first ten years on the market. In exchange, innovators must of course renounce the usual rewards they are otherwise entitled to, namely the patent-protected markup on the price of their product.

Socialized medicine allows a nation to exclude a U.S. product from its market if the U.S. firm does not make generous enough price concessions. Accordingly, what has developed is a system within which U.S. firms make large profits on new drugs in the U.S. market, but very low profits on sales everywhere else.

There is no disputing the fact that American consumers pay 30 to 300 percent more for the same prescription drugs as our counterparts in Canada, Europe, and the rest of the world.

Blame me for capitalism. Blame me for EpiPen.

The economy, virtually all the new income has gone to the top 10 percent, and we need to find those areas where we can actually make a change in that. And that includes enhancing manufacturing jobs in this country, it includes the ability to go to community college for free, it includes the ability to have debt-free higher education, it includes career technical education in our high schools. It also includes taking on the pharmaceutical companies on the extravagant prices that they're charging for the drugs. Americans need to stay healthy.

Drug prices are a problem. Access is a problem.

Patients are becoming aware that they're being taken for a ride by big pharma companies. They charge high prices and have never cared for India's healthcare. There are 23 million cases of cancer every year and India has a fair share of that.

The skyrocketing costs of insulin are simply unaffordable for too many Maine families, and no one should be forced to choose between life-saving medications and essentials like groceries or clothes for their kids.

There are no issues more personal than prescription drugs and the high prices Americans must pay to get the medicine they need.